Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Amortization of Deferred Charges: 2013-2025

Historic Amortization of Deferred Charges for Ironwood Pharmaceuticals (IRWD) over the last 13 years, with Sep 2025 value amounting to $418,000.

  • Ironwood Pharmaceuticals' Amortization of Deferred Charges rose 19.43% to $418,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 19.80%. This contributed to the annual value of $1.9 million for FY2024, which is 7.57% down from last year.
  • Ironwood Pharmaceuticals' Amortization of Deferred Charges amounted to $418,000 in Q3 2025, which was up 0.48% from $416,000 recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Amortization of Deferred Charges registered a high of $6.1 million during Q4 2021, and its lowest value of $350,000 during Q3 2024.
  • For the 3-year period, Ironwood Pharmaceuticals' Amortization of Deferred Charges averaged around $474,000, with its median value being $418,000 (2025).
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Amortization of Deferred Charges tumbled by 93.49% in 2022 and then spiked by 46.75% in 2023.
  • Over the past 5 years, Ironwood Pharmaceuticals' Amortization of Deferred Charges (Quarterly) stood at $6.1 million in 2021, then tumbled by 93.49% to $400,000 in 2022, then soared by 46.75% to $587,000 in 2023, then dropped by 29.30% to $415,000 in 2024, then climbed by 19.43% to $418,000 in 2025.
  • Its last three reported values are $418,000 in Q3 2025, $416,000 for Q2 2025, and $416,000 during Q1 2025.